Skip to content

Single center, double-blind, randomized, parallel trial to evaluate the efficacy of food containing yeast on human gastrointestinal function

Single center, double-blind, randomized, parallel trial to evaluate the efficacy of food containing yeast on human gastrointestinal function - Evaluation study of the efficacy on human gastrointestinal function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020476
Enrollment
50
Registered
2016-01-07
Start date
2016-01-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Slight constipation

Interventions

food containing yeast 12-week intake(Three times a day intake) Placebo 12-week intake(Three times a day intake)

Sponsors

Prime Biz Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Japanese male and female ages 20-64 years old (inclusive) (2)Subjects with tendency for constipation at 3 to 5 times of defecation per week (3)Subjects who take 3 meals per day regularly (4)Willing and able to provide signed written informed consent

Exclusion criteria

Exclusion criteria: (1)Subjects with severe hepatic, renal, cardiac, pulmonary, gastrointestinal, hematologic, endocrine and metabolic diseases / disorders (2)Subjects who suffer from diseases/ disorders with continuous medical treatment or with medical history of severe diseases/ disorders needed medical treatment (3)Subjects who suffer from diseases/ disorders that affects the study and are receiving medical treatment from medical institution or have surgical history of digestive system ( except appendectomy) (4)Subjects who suffer from diseases/ disorders that affects bowel movement such as irritable bowel syndrome or ulcerative colitis etc or have medical history of above-mentioned diseases/ disorders (5)Subjects with history of sensitivity to the ingredients (6)Pregnant, lactating women or willing to be pregnancy during the study (7)Subjects who take any kind of medicine ( laxative, intestinal drug etc) that possibly affect bowel movement (8)Subjects who take supplements and/or functional foods (including Food for Specified Health Uses [FOSHU]) regularly that possibly affect bowel movement (9)Subjects who have a habit of eating lactic fermenting beverage or food or Lactobacillus preparation that contain many lactobacillus, food fortified with dietary fiber and/or oligosaccharide 3 and more times per week (10)Any candidate considered to be unsuitable for enrollment based on his/her answers of life style questionnaire (11)Subjects who had participated in other clinical trials including drug and food within 1 month. (12)Any candidate considered to be unsuitable for enrollment in the opinion of the principal investigator

Design outcomes

Primary

MeasureTime frame
Defecation frequency, defecation days(After intervention 11-12 weeks after)

Secondary

MeasureTime frame
Amount of defection, fecal condition(form, color, smell, feeling after defecation)

Countries

Japan

Contacts

Public ContactShigeru Imai

CROee Inc. Evidence Division

imai@croee.com03-5953-2108

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026